Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,197Revenue $M2,617Net Margin (%)-26.2Z-Score0.7
Enterprise Value $M13,050EPS $-6.1Operating Margin %-16.3F-Score4
P/E(ttm))0Cash Flow Per Share $7.2Pre-tax Margin (%)-21.4Higher ROA y-yN
Price/Book3.410-y EBITDA Growth Rate %0Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %0Current Ratio1.4Lower Leverage y-yY
Price/Cash Flow3.9y-y EBITDA Growth Rate %0ROA % (ttm)-10.4Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-130.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M152ROI % (ttm)-16.6Gross Margin Increase y-yN

Gurus Latest Trades with ENDP

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ENDPJulian Robertson 2014-03-31 Buy 0.51%$64.3 - $81.49
($70.78)
$ 66.97-5%New holding, 22800 sh.22,800
ENDPGeorge Soros 2014-03-31 Buy 0.13%$64.3 - $81.49
($70.78)
$ 66.97-5%New holding, 198503 sh.198,503
ENDPWallace Weitz 2014-03-31 Add0.12%$64.3 - $81.49
($70.78)
$ 66.97-5%Add 12.33%500,920
ENDPJoel Greenblatt 2014-03-31 Sold Out -0.64%$64.3 - $81.49
($70.78)
$ 66.97-5%Sold Out0
ENDPDavid Dreman 2014-03-31 Sold Out -0.01%$64.3 - $81.49
($70.78)
$ 66.97-5%Sold Out0
ENDPRay Dalio 2014-03-31 Sold Out -0.01%$64.3 - $81.49
($70.78)
$ 66.97-5%Sold Out0
ENDPSteve Mandel 2013-12-31 Buy 1.3%$43.64 - $67.25
($57.05)
$ 66.9717%New holding, 4340000 sh.4,340,000
ENDPWallace Weitz 2013-12-31 Buy 1%$43.64 - $67.25
($57.05)
$ 66.9717%New holding, 445920 sh.445,920
ENDPJohn Griffin 2013-12-31 Add0.7%$43.64 - $67.25
($57.05)
$ 66.9717%Add 14.29%8,000,000
ENDPDavid Dreman 2013-12-31 Buy 0.01%$43.64 - $67.25
($57.05)
$ 66.9717%New holding, 1378 sh.1,378
ENDPJoel Greenblatt 2013-12-31 Reduce-0.18%$43.64 - $67.25
($57.05)
$ 66.9717%Reduce -23.94%397,016
ENDPJoel Greenblatt 2013-09-30 Add0.12%$36.3 - $45.61
($40.18)
$ 66.9767%Add 18.5%521,987
ENDPJohn Griffin 2013-09-30 Add0.11%$36.3 - $45.61
($40.18)
$ 66.9767%Add 2.94%7,000,000
ENDPRay Dalio 2013-09-30 Buy 0.01%$36.3 - $45.61
($40.18)
$ 66.9767%New holding, 14272 sh.14,272
ENDPJohn Griffin 2013-06-30 Buy 3%$30.73 - $39.3
($35.95)
$ 66.9786%New holding, 6800000 sh.6,800,000
ENDPJoel Greenblatt 2013-06-30 Add0.2%$30.73 - $39.3
($35.95)
$ 66.9786%Add 40.61%440,490
ENDPMario Gabelli 2013-06-30 Reduce$30.73 - $39.3
($35.95)
$ 66.9786%Reduce -23.34%43,350
ENDPMario Gabelli 2013-03-31 Buy 0.01%$25.06 - $31.66
($29.2)
$ 66.97129%New holding, 56550 sh.56,550
ENDPJohn Hussman 2013-03-31 Sold Out -0.72%$25.06 - $31.66
($29.2)
$ 66.97129%Sold Out0
ENDPDavid Dreman 2013-03-31 Sold Out -0.07%$25.06 - $31.66
($29.2)
$ 66.97129%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ENDP is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ENDP George Soros 2014-03-31198,5030.130.13New Buy
ENDP Julian Robertson 2014-03-3122,8000.010.51New Buy
ENDP Wallace Weitz 2014-03-31500,9200.331.1+12.33%
ENDP - CALLJohn Griffin 2014-03-31676,6000.440.51
ENDP John Griffin 2014-03-318,000,0005.256.1
ENDP Steve Mandel 2014-03-314,178,7032.741.2-3.72%
ENDP Mario Gabelli 2014-03-3130,5500.020.01-8.4%
ENDP David Dreman 2014-03-31000Sold Out
ENDP Ray Dalio 2014-03-31000Sold Out
ENDP Joel Greenblatt 2014-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ENDP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DELUCCA JOHNDirector 2014-06-09Sell6,764$68.83-2.7view
MANOGUE CAROLINE BExec. V.P., CLO & Secy 2014-05-29Sell175,033$72.02-7.01view
DELUCCA JOHNDirector 2014-05-01Sell8,094$66.311view
DELUCCA JOHNDirector 2014-04-01Sell10,384$68.46-2.18view
Gergel Ivan P.EVP, R&D and CSO 2014-03-10Sell75,637$72.47-7.59view
HIGGINS ARTHUR JDirector 2014-03-10Buy5,000$73-8.26view
Hutson Nancy JDirector 2014-03-10Sell5,000$72.12-7.14view
MANOGUE CAROLINE BExec. V.P., CLO & Secy 2013-08-26Sell145,592$39.469.97view
KIMMEL ROGER HDirector 2013-08-08Buy5,478$36.583.48view
Gergel Ivan P.EVP, R&D and CSO 2013-04-24Sell138,225$36.4583.73view

Press Releases about ENDP :

    Quarterly/Annual Reports about ENDP:

    News about ENDP:

    Articles On GuruFocus.com
    Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium Apr 23 2014 
    H/C -- winner. Down Mar 02 2013 
    greenblatt - low Jan 22 2013 
    comment on ENDP Nov 28 2012 
    comment on ENDP Jul 09 2012 
    Weekly Top Insider Buys: MDT, KMI, WIN, ENDP, OC Jun 25 2012 
    Weekly CEO Buys Highlight: UTHR, TAT, PMC, BRCD, ENDP Jun 16 2012 
    Endo Pharmaceuticals Holdings Inc. (ENDP) EVP, CFO Alan G Levin sells 16,627 Shares Dec 09 2010 
    Endo Pharmaceuticals Holdings Inc. Reports Operating Results (10-Q) Nov 02 2010 
    Endo Pharmaceuticals Holdings Inc. Reports Operating Results (10-Q) Aug 02 2010 


    More From Other Websites
    Will Merck & Co. (MRK) Surprise This Earnings Season? Jul 28 2014
    Is Pfizer Inc. (PFE) Poised to Beat Earnings Estimates? Jul 28 2014
    Will Express Scripts Miss Earnings Estimates this Season? Jul 28 2014
    Will Vertex Pharmaceuticals (VRTX) Loss be Below Estimates? Jul 28 2014
    Can Hospira (HSP) Keep the Earnings Streak Alive? Jul 28 2014
    Bayer/Amgen's Nexavar Does Not Show Resilience in Study Jul 25 2014
    Endo completes acquisition of Grupo Farmaceutico Somar® Jul 24 2014
    Will AbbVie (ABBV) Surprise This Earnings Season? Jul 24 2014
    Will Alexion Pharmaceuticals (ALXN) Miss This Earnings Season? Jul 23 2014
    Will Generics Eat Into Eli Lilly's (LLY) Q2 Earnings? Jul 23 2014
    Will Bristol-Myers Squibb (BMY) Disappoint This Earnings Season? Jul 23 2014
    Celgene (CELG) Set to Beat Earnings Estimates on Strong Revs Jul 22 2014
    Will Biogen Idec Inc. (BIIB) Surprise this Earnings Season? Jul 22 2014
    AcelRx Pharmaceuticals (ACRX) Jumps: Stock Adds 11.7% in Session Jul 21 2014
    ImmunoGen (IMGN) Soars: Stock Up 8.8% Jul 21 2014
    Endo's Paladin Labs Reports Canadian Introduction Of Veregen Jul 16 2014
    Endo to Announce Second Quarter 2014 Financial Results on July 31, 2014 Jul 15 2014
    Endo to Announce Second Quarter 2014 Financial Results on July 31, 2014 Jul 15 2014
    MediWound (MDWD) Falls: Stock Goes Down 6.1% Jul 14 2014
    BioDelivery Jumps after Pain Drug Performs Well in Study Jul 08 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide